ICD-10-CM 2026 · Effective October 1, 2025

ICD-10 C79.9

Billable / Specific HCC v28: 8 CC

Secondary malignant neoplasm of unspecified site

C79
Block
2
Synonyms
189
LCDs
21
Payer Policies
7
Linked CPTs

About ICD-10-CM C79.9

ICD-10-CM code C79.9 represents Secondary malignant neoplasm of unspecified site. This is a billable/specific code in the chapter (block C79). The 2026 edition of ICD-10-CM C79.9 became effective on October 1, 2025.

Coding Tips for C79.9

Specialist guidance from the PayerReady Medical Coding Team. Specificity warnings, HCC capture rules, sequencing notes.

HCC capture: document with MEAT each year

C79.9 is a CMS-HCC v28 risk-adjustment code (category 8). To count for the patient Risk Adjustment Factor (RAF), document the diagnosis with MEAT language each calendar year: Monitored, Evaluated, Assessed, Treated. A diagnosis on the problem list alone does not satisfy CMS RADV audit standards. Include the diagnosis in the assessment with current status and current treatment plan.

Inpatient DRG impact: CC

C79.9 is designated CC for MS-DRG grouping. On inpatient claims, this code can shift the DRG to the with-CC variant when documented as a present-on-admission secondary diagnosis. Hospital CDI programs flag CC opportunities during chart review. Failure to capture this code may leave 30 to 80 percent of the inpatient stay revenue unrealized.

Inclusion Terms / Approximate Synonyms

Clinical terms and conditions classified under C79.9. Per CMS ICD-10-CM Tabular 2026.

  • Metastatic cancer NOS
  • Metastatic disease NOS

Type 1 Excludes

Pure excludes, these codes can never be coded together with C79.9. The conditions are mutually exclusive (e.g., congenital vs acquired forms).

  • carcinomatosis NOS (C80.0)
  • generalized cancer NOS (C80.0)
  • malignant (primary) neoplasm of unspecified site (C80.1)

Medicare Advantage HCC Impact

CMS-HCC v28 (current)
Category 8
ESRD-HCC
Category 8
RxHCC (Part D)
Category 8

Capture this diagnosis annually for accurate risk adjustment. Missed HCC captures are the #1 revenue leak in Medicare Advantage risk programs.

Inpatient DRG Impact, CC

codes Secondary malignant neoplasm of unspecified site. As a Complication/Comorbidity (CC), this contributes to DRG severity adjustment when documented alongside the principal diagnosis.

Medicare LCD Coverage for C79.9

Local Coverage Determinations (LCDs) from CMS MACs that list C79.9 as a covered diagnosis.

189 LCDs

Showing top 10 of 189 total . Click a CPT for full coverage scope.

CMS LCD: Billing and Coding: MolDX: Germline testing for use of PARP inhibitors
Article ID: 55294, Effective: 2026-02-19 00:00:00, 68 covered, 0 non-covered
CPT 81479 →
CMS LCD: Billing and Coding: MolDX: Germline testing for use of PARP inhibitors
Article ID: 55294, Effective: 2026-02-19 00:00:00, 68 covered, 0 non-covered
CPT 81162 →
CMS LCD: Billing and Coding: Transesophageal Echocardiography (TEE)
Article ID: 52868, Effective: 2025-01-01 00:00:00, 773 covered, 0 non-covered
CPT 93320 →
CMS LCD: Billing and Coding: Transesophageal Echocardiography (TEE)
Article ID: 52868, Effective: 2025-01-01 00:00:00, 773 covered, 0 non-covered
CPT 93313 →
CMS LCD: Billing and Coding: Transesophageal Echocardiography (TEE)
Article ID: 52868, Effective: 2025-01-01 00:00:00, 773 covered, 0 non-covered
CPT 93312 →
CMS LCD: Billing and Coding: Transesophageal Echocardiography (TEE)
Article ID: 52868, Effective: 2025-01-01 00:00:00, 773 covered, 0 non-covered
CPT 76376 →
CMS LCD: Billing and Coding: Transesophageal Echocardiography (TEE)
Article ID: 52868, Effective: 2025-01-01 00:00:00, 773 covered, 0 non-covered
CPT 93318 →
CMS LCD: Billing and Coding: Transesophageal Echocardiography (TEE)
Article ID: 52868, Effective: 2025-01-01 00:00:00, 773 covered, 0 non-covered
CPT 93317 →
CMS LCD: Billing and Coding: Transesophageal Echocardiography (TEE)
Article ID: 52868, Effective: 2025-01-01 00:00:00, 773 covered, 0 non-covered
CPT 76377 →
CMS LCD: Billing and Coding: Transesophageal Echocardiography (TEE)
Article ID: 52868, Effective: 2025-01-01 00:00:00, 773 covered, 0 non-covered
CPT C8927 →

Commercial Payer Coverage

Coverage policies from major commercial payers referencing C79.9.

21 policies

5 Medicare

Oral Anticancer Drugs - Policy Article
Policy ID: ART-52479
Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
Policy ID: ART-52480
Billing and Coding: Transesophageal Echocardiography (TEE)
Policy ID: ART-52868
Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID� Update
Policy ID: ART-53101
Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID�
Policy ID: ART-54188

CPT Codes Commonly Billed with C79.9

Procedures frequently paired with this diagnosis based on PayerReady's Dx↔Px linkage data.

7 linkages
  • C8925 CMS LCD: Billing and Coding: Transesophageal Echocardiography (TEE) CMS LCD
  • C8927 CMS LCD: Billing and Coding: Transesophageal Echocardiography (TEE) CMS LCD
  • C8926 CMS LCD: Billing and Coding: Transesophageal Echocardiography (TEE) CMS LCD
  • 75574 CMS LCD: Billing and Coding: Coronary Computed Tomography Angiography (CCTA) CMS LCD
  • 75573 CMS LCD: Billing and Coding: Coronary Computed Tomography Angiography (CCTA) CMS LCD
  • 75572 CMS LCD: Billing and Coding: Coronary Computed Tomography Angiography (CCTA) CMS LCD
  • 75571 CMS LCD: Billing and Coding: Coronary Computed Tomography Angiography (CCTA) CMS LCD

Convert C79.9 to ICD-9-CM

Per CMS General Equivalence Mappings (GEMs), useful for legacy data review and historical claim analysis.

ICD-10ICD-9Mapping Flags
C79.9 19889 10000

Flags format (5 digits): Approximate · No Map · Combination · Scenario · Choice List. Source: CMS 2017 GEMs (final version).

ICD-10 C79.9, Billing FAQ

Is ICD-10 code C79.9 billable? +

Yes, C79.9 is a billable ICD-10-CM code that can appear as a primary or secondary diagnosis on claims.

What other names or terms map to C79.9? +

ICD-10 C79.9 includes: Metastatic cancer NOS; Metastatic disease NOS.

What codes are Type 1 Excludes for C79.9? +

Type 1 Excludes (never code together with C79.9): carcinomatosis NOS (C80.0); generalized cancer NOS (C80.0); malignant (primary) neoplasm of unspecified site (C80.1)

Does C79.9 affect Medicare Advantage HCC risk adjustment? +

Yes. C79.9 maps to CMS-HCC v28 category 8. Capture this diagnosis annually for accurate Medicare Advantage risk score.

Is C79.9 a CC or MCC for inpatient DRG? +

Yes, this code is designated as CC. Documenting as a secondary diagnosis on inpatient claims can shift the DRG to a higher-weighted category.

What CPT codes are commonly billed with C79.9? +

Procedures frequently paired with C79.9 include: C8925, C8927, C8926, 75574, 75573.

What ICD-9 codes does C79.9 map to? +

Per CMS GEMs, C79.9 maps to ICD-9 codes: 19889. Useful for legacy data review and historical claim analysis.

Get the full PayerReady toolkit

Free access to CPT/ICD-10 lookup, denial appeals, fee comparator, and claim auditing with credentialing enrollment.

Start free →

Run this code through our claim audit tool

Check NCCI bundling, MUE limits, and modifier logic before submission.

Try the auditor →

Did this page help?

Quick signal so we know what to improve.

Thanks!

If you want a code reference page that doesn't exist yet, email coding@payerready.com.

Sorry to hear that.

Tell us what's missing or wrong: coding@payerready.com. We respond within 5 business days.

Reviewed by the PayerReady Medical Coding Team

Verified against the CMS 2026 code set on June 1, 2026.

Powered by 11K CPT · 98K ICD-10 · 860K MPFS rates · 4.5M NCCI edits · 9.5M NPIs. Our data methodology · About our coding team

Faster Approvals

Ready to Cut Your Enrollment Timeline in Half?

Join providers in all 50 states who handed off credentialing to a dedicated specialist. Create your free account in minutes and start enrolling the same day.

All 50 States Covered
No Long-Term Contracts
HIPAA HIPAA Compliant Platform
Dedicated Specialist Included